“AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters news agency.” [Source: reuters.com]
There is growing concern over the use of ‘genetic vaccines’ like the one being developed by AstraZeneca. The active principle behind such vaccines involves introducing genetic material (DNA or RNA) into cells. This technology is still in the experimental stage and is associated with serious side effects. The long-term side effects, due to the introduction of artificial genes into the DNA of human cells, are currently completely uncontrollable.
A mass use of this technology could potentially change the genetic makeup of mankind irreversibly, for generations to come. Despite this, amidst the challenge of the corona pandemic, all concerns about this technology would appear to have been thrown overboard. If pharmaceutical companies and some governments get their way, millions of people will be injected with these high-risk vaccines and essentially treated as human guinea pigs. The sole beneficiaries will be the pharmaceutical ‘business with disease’ and its shareholders.
To learn more about our position on vaccines, download a free copy of our brochure, ‘Can we make our vaccines safer?’